Just another WordPress site
Why Funding For Medical Device Innovation Doesn?t Need To Come From Government While funding for medical device innovation is a good thing, it doesn?t necessarily need to come from government, whether that?s in the form of tax breaks or grants. Robert Langer, an MIT professor and this year?s recipient of the Medical Design Excellence Awards …
Continue reading “Funding For Medical Device Innovation Doesn?t Need To Come From Government”
Why Must Any Strong Medical Device Marketing Plan Use Key Opinion Leaders? The 2013 Deloitte annual survey of U.S. physicians reveals that they still believe doctors have the most influence in choosing equipment for patients and procedures. This news, highlighted in an article on the Becker?s ASC Review website, could have a big influence on …
Continue reading “Why Must Any Strong Medical Device Marketing Plan Use Key Opinion Leaders”
Facing a patent cliff and erosion from generic drugs, many pharmaceutical companies are relying on partnerships with biotech companies for innovation and development. Shifting dynamics are now prompting some biotechs to seek more balanced deals than in the past, sharing rewards as well as risks, according to an article on the BioWorld Today website. ?Pharmas …
Continue reading “Why Are Pharma Companies Relying On Partnerships With Biotechs?”
As some of you may know, the FDA/CMS (Centers for Medicare and Medical Services) have been (very) late in issuing their final ruling as to when physician Sunshine Act reporting will begin. Those of you who follow me via Twitter and on the i3 Community site know that I’ve been posting updates about the Sunshine …
Continue reading “FDA/CMS Announce Long Delayed Ruling on Sunshine Act”
I ran across this interesting article about a significant trend in the pharmaceutical and biotech industry. Bloomberg Article In a nutshell, drug makers are shifting their focus from cutting costs to filling pipelines through mergers and acquisitions. Next year could top the 2,076 deals worth $166 billion announced in the past 12 months. “What tends …
Continue reading “Pharmaceutical/Biotech Mergers & Acquisitions Expected to Continue”
Back in December I wrote a blog post about the Centers for Medicare & Medicaid Services (CMS) rule change for reporting on the Physicians Payment Sunshine Act. Original post here: http://i3.infinityinfo.com/blogs/entry/sunshine-act-compliance-deadlines-extended The CMS had decided to extend the data collection start date from January 1, 2012 to ?some later date?. A few days ago, on …
Continue reading “Update on Sunshine Act Compliance Deadlines”
The 11th Annual iPharma Connect Conference was held last week in Philadelphia. This year?s theme was ?Digital Innovation for Marketing Decision Makers in the Life Sciences Industry?. I will share some notes on the conference and key trends and ideas that might provide you some value as well. At its core, digital marketing is about …
Continue reading “iPharma Connect Conference?The New Commercial Model”
The FDA recently announced (some) updated social media guidelines for pharmaceutical and medical device firms. The actual title of these